Senvest Capital Inc. Announces Death of Chief Executive Officer and Chairman of the Board

(TSX:SEC), MONTREAL, Dec. 27, 2025 (GLOBE NEWSWIRE) — Senvest Capital Inc. (the “Corporation” or “Senvest”) (TSX: SEC) announces with profound sadness the passing of its founder and long-time leader, Victor Mashaal, who served as President, Chief Executive Officer, and Chairman of the Board of Directors. Victor passed away at the age of 87 following a […]

Senvest Capital Inc. Announces Death of Chief Executive Officer and Chairman of the Board

Senvest Capital Inc. Announces Death of Chief Executive Officer and Chairman of the Board GlobeNewswire December 27, 2025 MONTREAL, Dec. 27, 2025 (GLOBE NEWSWIRE) — Senvest Capital Inc. (the “Corporation” or “Senvest”) (TSX: SEC) announces with profound sadness the passing of its founder and long-time leader, Victor Mashaal, who served as President, Chief Executive Officer,

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Charming Medical Limited- MCTA

NEW YORK, NY / ACCESS Newswire / December 27, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Charming Medical Limited ("Charming Medical" or the "Company") (NASDAQ:MCTA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Charming Medical and certain of its officers

Best Semaglutide For Weight Loss 2026: Is MEDVi the Best GLP-1 Supplier for a Sustainable Online Weight Loss Program?

New York City, NY, Dec. 27, 2025 (GLOBE NEWSWIRE) — Intro As medical weight loss continues to evolve in 2026, the landscape of GLP-1 therapies has reached a pivotal moment with expanded FDA-recognized access pathways, emerging treatment formats, and enhanced clinical support structures designed to optimize sustainable weight management outcomes. Driven by advancements in semaglutide

Best Semaglutide For Weight Loss 2026: Is MEDVi the Best GLP-1 Supplier for a Sustainable Online Weight Loss Program?

Best Semaglutide For Weight Loss 2026: Is MEDVi the Best GLP-1 Supplier for a Sustainable Online Weight Loss Program? Best semaglutide for weight loss in 2026 explained. Explore FDA-approved options, GLP-1 programs, safety, access pathways, and MEDVi's structured online weight loss platform. GlobeNewswire December 27, 2025 New York City, NY, Dec. 27, 2025 (GLOBE NEWSWIRE)

INSP IMPORTANT DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Inspire Medical Systems, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important January 5 Deadline in Securities Class Action – INSP

NEW YORK CITY, NY / ACCESS Newswire / December 27, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Inspire Medical Systems, Inc. (NYSE:INSP) between August 6, 2024 and August 4, 2025, both dates inclusive (the "Class Period"), of the important January 5, 2026 lead plaintiff

Best NAD+ Injection for 2026: Sprout Health Lists Compounded NAD+ at $149 First Month as Telehealth Longevity Programs Expand

ENCINITAS, Dec. 27, 2025 (GLOBE NEWSWIRE) — Disclaimer: This article is for informational purposes only–not medical advice. Always consult a qualified healthcare professional before starting any prescription treatment. NAD+ is a naturally occurring coenzyme; pharmacy-compounded NAD+ injections require individual prescriptions and are not FDA-approved as finished products. A licensed clinician must evaluate you, and prescription

Best NAD+ Injection for 2026: Sprout Health Lists Compounded NAD+ at $149 First Month as Telehealth Longevity Programs Expand

Best NAD+ Injection for 2026: Sprout Health Lists Compounded NAD+ at $149 First Month as Telehealth Longevity Programs Expand Prescription NAD+ Injection Access, At-Home Administration Models, Compounding Standards, and What Consumers Should Know Before Choosing a Telehealth NAD+ Provider in 2026 GlobeNewswire December 27, 2025 ENCINITAS, Dec. 27, 2025 (GLOBE NEWSWIRE) — Disclaimer: This article

Scroll to Top